+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Use of Medicaid data to explore community characteristics associated with HIV prevalence among beneficiaries with schizophrenia



Use of Medicaid data to explore community characteristics associated with HIV prevalence among beneficiaries with schizophrenia



Public Health Reports 126 Suppl 3: 89-101



People with severe mental illness (SMI) may be at increased risk for several adverse health conditions, including HIV/AIDS. This disproportionate disease burden has been studied primarily at the individual rather than community level, in part due to the rarity of data sources linking individual information on medical and mental health characteristics with community-level data. We demonstrated the potential of Medicaid data to address this gap. We analyzed data on Medicaid beneficiaries with schizophrenia from eight states that account for 66% of cumulative AIDS cases nationally. Across 44 metropolitan statistical areas (MSAs), the treated prevalence of HIV among adult Medicaid beneficiaries diagnosed with schizophrenia was 1.56% (standard deviation = 1.31%). To explore possible causes of variation, we linked claims files with a range of MSA social and contextual variables including local AIDS prevalence rates, area-based economic measures, crime rates, substance abuse treatment resources, and estimates of injection drug users (IDUs) and HIV infection among IDUs, which strongly predicted community infection rates among people with schizophrenia. Effective strategies for HIV prevention among people with SMI may include targeting prevention efforts to areas where risk is greatest; examining social network links between IDU and SMI groups; and implementing harm reduction, drug treatment, and other interventions to reduce HIV spread among IDUs. Our findings also suggest the need for research on HIV among people with SMI that examines geographical variation and demonstrates the potential use of health-care claims data to provide epidemiologic insights into small-area variations and trends in physical health among those with SMI.

(PDF emailed within 1 workday: $29.90)

Accession: 056791107

Download citation: RISBibTeXText

PMID: 21836742


Related references

Prevalence of diagnosed HIV disease among medicaid beneficiaries with schizophrenia in U.S. metropolitan areas. Journal of Nervous and Mental Disease 198(9): 682-686, 2010

Effects of state-level medicaid policies and patient characteristics on time to breast cancer surgery among medicaid beneficiaries. Breast Cancer Research and Treatment 158(3): 573-581, 2017

Potential adult Medicaid beneficiaries under the Patient Protection and Affordable Care Act compared with current adult Medicaid beneficiaries. Annals of Family Medicine 11(5): 406-411, 2014

Medication continuity among Medicaid beneficiaries with schizophrenia and bipolar disorder. Psychiatric Services 64(9): 878-885, 2014

Incidence and consistency of antiretroviral use among HIV-infected medicaid beneficiaries with schizophrenia. Journal of Clinical Psychiatry 62(3): 174-178, 2001

Assisted living and use of health services among medicaid beneficiaries with schizophrenia. Journal of Mental Health Policy and Economics 6(2): 59-65, 2003

Outcomes of medicaid beneficiaries with schizophrenia receiving clozapine only or antipsychotic combinations. Psychiatric Services 66(2): 127-133, 2015

State and demographic variation in use of depot antipsychotics by Medicaid beneficiaries with schizophrenia. Psychiatric Services 65(1): 121-124, 2014

Outcomes for Medicaid beneficiaries with schizophrenia under a prepaid mental health carve-out. Journal of Behavioral Health Services and Research 26(4): 442-450, 1999

Analysis of West Virginia medicaid claims data for the prevalence of medical conditions and use of drugs likely to cause QT prolongation in patients with schizophrenia. Current Therapeutic Research, Clinical and Experimental 64(8): 538-550, 2003

State Variation in the Delivery of Comprehensive Services for Medicaid Beneficiaries with Schizophrenia and Bipolar Disorder. Community Mental Health Journal 51(5): 523-534, 2016

Adherence to treatment with antipsychotic medication and health care costs among Medicaid beneficiaries with schizophrenia. American Journal of Psychiatry 161(4): 692-699, 2004

Antipsychotic polypharmacy trends among Medicaid beneficiaries with schizophrenia in San Diego County, 1999-2004. Psychiatric Services 58(7): 1007-1010, 2007

Emergency department utilization among Medicaid beneficiaries with schizophrenia and diabetes: the consequences of increasing medical complexity. Schizophrenia Research 152(2-3): 490-497, 2014

A longitudinal study of the prevalence of migraine headaches among Idaho Medicaid beneficiaries. American Journal of Epidemiology 151(11 Supplement): S45, June 1, 2000